April 16, 2025 - 01:47

WELL Health Technologies has recently announced an impressive earnings and revenue forecast, estimating revenues to reach between CAD 1.40 billion and CAD 1.45 billion by 2025. This projection follows a notable increase in their reported sales, which rose to CAD 920 million in 2024, marking a significant jump from CAD 776 million in the previous year. This upward trajectory highlights the company's strong performance within the healthcare technology sector.
The announcement has positively impacted WELL's market position, evidenced by a 2% increase in stock price over the past week. This rise aligns with broader market trends, as the overall market experienced a gain of 7%. The optimistic financial outlook and robust earnings guidance suggest that WELL Health Technologies is well-positioned for continued growth. Investors and stakeholders alike are closely monitoring these developments, as the company appears to be navigating the healthcare landscape effectively and capitalizing on emerging opportunities.
May 28, 2026 - 03:00
Colorectal cancer risk linked to gut microbiome alterations | Harvard T.H. Chan School of Public HealthEven more than ten years after a precancerous growth called an adenoma is removed from the colon, the gut microbiome and its related metabolites may still show lasting changes that increase the...
May 27, 2026 - 14:17
A Great Athlete is a Healthy Athlete: Muaz’s Journey to Becoming a Fitness CaptainEvery May, Special Olympics marks Fitness and Sport Month, a time to highlight how physical activity boosts health, performance, and overall well-being for athletes. This year, I sat down with Muaz...
May 26, 2026 - 20:41
Popular fruit may help protect your skin from the sun, new study suggestsA new study suggests that eating grapes might offer a natural layer of protection against the sun`s harmful rays. Published in the journal ACS Nutrition Science, the research indicates that...
May 26, 2026 - 16:16
Optima Health Leads These 3 Undiscovered Gems in the United KingdomAs the FTSE 100 and FTSE 250 struggle under pressure from weak global signals and disappointing trade numbers out of China, many investors are shifting their attention away from big-name blue chips...